ArticleCancers2025

Predicting Toxicities and Survival Outcomes in De Novo Metastatic Hormone-Sensitive Prostate Cancer Using Clinical Features, Routine Blood Tests and Their Early Variations.

Giuseppe Salfi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.